These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 16123483)

  • 21. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities.
    Huang PP; Li SZ; Han MZ; Xiao ZJ; Yang RC; Qiu LG; Han ZC
    Thromb Haemost; 2004 Mar; 91(3):606-9. PubMed ID: 14983238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Autologous peripheral blood stem cell transplantation for the treatment of lower extremity arterial occlusive disease].
    Wang L; Dong SM; Jiang QZ; Nan JL; Liu YG; Li SR; Feng XM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):345-8. PubMed ID: 16776930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Majdzadeh R; Nedjat S
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008347. PubMed ID: 22161427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of neovascularization with mobilized blood cells transplantaion: supply of angioblasts and angiogenic cytokines.
    Zhou B; Liu PX; Lan HF; Fang ZH; Han ZB; Ren H; Poon MC; Han ZC
    J Cell Biochem; 2007 Sep; 102(1):183-95. PubMed ID: 17390342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia.
    Ishida A; Ohya Y; Sakuda H; Ohshiro K; Higashiuesato Y; Nakaema M; Matsubara S; Yakabi S; Kakihana A; Ueda M; Miyagi C; Yamane N; Koja K; Komori K; Takishita S
    Circ J; 2005 Oct; 69(10):1260-5. PubMed ID: 16195628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse events during treatment of critical limb ischemia with autologous peripheral blood mononuclear cell implant.
    Jonsson TB; Larzon T; Arfvidsson B; Tidefelt U; Axelsson CG; Jurstrand M; Norgren L
    Int Angiol; 2012 Feb; 31(1):77-84. PubMed ID: 22330628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients.
    Martino M; Recchia AG; Moscato T; Fedele R; Neri S; Gentile M; Alati C; Vincelli ID; Piro E; Penna G; Musolino C; Ronco F; Molica S; Morabito F
    Cytotherapy; 2015 Oct; 17(10):1485-93. PubMed ID: 26188967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs.
    Kawamura A; Horie T; Tsuda I; Abe Y; Yamada M; Egawa H; Iida J; Sakata H; Onodera K; Tamaki T; Furui H; Kukita K; Meguro J; Yonekawa M; Tanaka S
    J Artif Organs; 2006; 9(4):226-33. PubMed ID: 17171401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of purified CD34+ cells in the treatment of critical limb ischemia.
    Dong Z; Chen B; Fu W; Wang Y; Guo D; Wei Z; Xu X; Mendelsohn FO
    J Vasc Surg; 2013 Aug; 58(2):404-411.e3. PubMed ID: 23611711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome From a Randomized Controlled Clinical Trial　- Improvement of Peripheral Arterial Disease by Granulocyte Colony-Stimulating Factor-Mobilized Autologous Peripheral-Blood-Mononuclear Cell Transplantation (IMPACT).
    Horie T; Yamazaki S; Hanada S; Kobayashi S; Tsukamoto T; Haruna T; Sakaguchi K; Sakai K; Obara H; Morishita K; Saigo K; Shintani Y; Kubo K; Hoshino J; Oda T; Kaneko E; Nishikido M; Ioji T; Kaneda H; Fukushima M;
    Circ J; 2018 Jul; 82(8):2165-2174. PubMed ID: 29877199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.
    Spitzer G; Adkins D; Mathews M; Velasquez W; Bowers C; Dunphy F; Kronmueller N; Niemeyer R; McIntyre W; Petruska P
    Bone Marrow Transplant; 1997 Dec; 20(11):921-30. PubMed ID: 9422470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Outcomes of using autologous peripheral-blood stem cells in patients with chronic lower arterial insufficiency].
    Maksimov AV; Kiiasov AP; Plotnikov MV; Maianskaia SD; Shamsutdinova II; Gazizov IM; Mavlikeev MO
    Angiol Sosud Khir; 2011; 17(2):11-5. PubMed ID: 21983456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of recombinant human interleukin 11 and granulocyte colony stimulating factor in mobilization for autologous peripheral blood stem cell transplantation].
    Zhu HY; DA WM; Gao CJ; Wang FF; Han XP; Li HH; Huang WR; Zhang YZ; Wang SH; Bo J; Jing Y; Jin HJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):345-9. PubMed ID: 18426662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.
    Murphy MP; Lawson JH; Rapp BM; Dalsing MC; Klein J; Wilson MG; Hutchins GD; March KL
    J Vasc Surg; 2011 Jun; 53(6):1565-74.e1. PubMed ID: 21514773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.
    Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L
    Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limb rescue: a new autologous-peripheral blood mononuclear cells technology in critical limb ischemia and chronic ulcers.
    De Angelis B; Gentile P; Orlandi F; Bocchini I; Di Pasquali C; Agovino A; Gizzi C; Patrizi F; Scioli MG; Orlandi A; Cervelli V
    Tissue Eng Part C Methods; 2015 May; 21(5):423-35. PubMed ID: 25341088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful collection and engraftment of autologous peripheral blood progenitor cells in poorly mobilized patients receiving high-dose granulocyte colony-stimulating factor.
    Cooper DL; Proytcheva M; Medoff E; Seropian SE; Snyder EL; Krause DS; Wu Y
    J Clin Apher; 2012 Nov; 27(5):235-41. PubMed ID: 22566214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF.
    Gazitt Y; Akay C; Thomas C
    Stem Cells Dev; 2006 Apr; 15(2):269-77. PubMed ID: 16646673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.